Singapore markets close in 1 hour 32 minutes

Jilin Province Huinan Changlong Bio-pharmacy Company Limited (8049.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
1.5000.000 (0.00%)
As of 11:13AM HKT. Market open.
Currency in HKD

Valuation measures4

Market cap (intra-day) 840.38M
Enterprise value 207.33M
Trailing P/E 5.15
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.91
Price/book (mrq)0.52
Enterprise value/revenue 0.22
Enterprise value/EBITDA 0.83

Trading information

Stock price history

Beta (5Y monthly) 0.15
52-week change 317.19%
S&P500 52-week change 324.69%
52-week high 31.950
52-week low 31.070
50-day moving average 31.625
200-day moving average 31.514

Share statistics

Avg vol (3-month) 3297.35k
Avg vol (10-day) 374.4k
Shares outstanding 5172.5M
Implied shares outstanding 6560.25M
Float 8128.99M
% held by insiders 125.23%
% held by institutions 10.23%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 418 Jun 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 17.61%
Operating margin (ttm)-2.03%

Management effectiveness

Return on assets (ttm)4.28%
Return on equity (ttm)9.58%

Income statement

Revenue (ttm)841.55M
Revenue per share (ttm)1.50
Quarterly revenue growth (yoy)0.20%
Gross profit (ttm)N/A
EBITDA 187.08M
Net income avi to common (ttm)148.21M
Diluted EPS (ttm)0.290
Quarterly earnings growth (yoy)-83.20%

Balance sheet

Total cash (mrq)658.06M
Total cash per share (mrq)1.17
Total debt (mrq)80.4M
Total debt/equity (mrq)5.43%
Current ratio (mrq)1.66
Book value per share (mrq)2.64

Cash flow statement

Operating cash flow (ttm)315.95M
Levered free cash flow (ttm)273.09M